A focus on Hidradenitis suppurativa lesions for symptom relief

Screen Shot 2016-03-19 at 1.42.44 AM

NEW YORK, OCTOBER 3, 2013 – The limited, and often transient, effectiveness of medical therapies for hidradenitis suppurativa puts the focus on treating the lesions independently to control symptoms, according to Dr. Ginette Hinds.

Although a long list of therapies, including biologics, has shown activity in hidradenitis suppurativa, only a proportion of patients respond, and cure is uncommon, said Dr. Hinds of Johns Hopkins University, Baltimore.

Data from studies of biologics, such as tumor necrosis factor (TNF)-alpha inhibitors, provide some examples. Hidradenitis suppurativa, as an inflammatory disease of the apocrine glands, is an obvious target of anti-inflammatory agents. A randomized controlled trial associated infliximab with clinical improvement relative to placebo (J. Am. Acad. Dermatol. 2013;27:1101-8), but Dr. Hinds cautioned that the benefit is not uniform.

READ THE FULL ARTICLE HERE: Focus on lesions for hidradenitis suppurativa symptom relief : Dermatology News

Tags:
0 Comments

Leave a reply

HSAWARENESS.ORG | Fighting for Hidradenitis suppurativa (HS), a.k.a Acne Inversa Patient and Doctor Awareness ©2018 hidradenitissuppurativaawareness.org  All Rights Reserved. Your use of this website constitutes explicit agreement to our Terms of Use and Privacy Policies. This website does not provide medical advice, diagnosis or treatment.

Log in with your credentials

Forgot your details?